Literature DB >> 12244125

Protein kinase CK2: a challenge to canons.

Lorenzo A Pinna1.   

Abstract

CK2 is an extremely conserved pleiotropic protein kinase with a growing list of more than 300 substrates, the majority of which are proteins implicated in signal transduction, gene expression and other nuclear functions. The CK2 phosphoacceptor sites are specified by multiple acidic residues, with the one at position +3 relative to the target residue being of crucial relevance. The CK2 holoenzyme is composed of two catalytic subunits (alphaalpha, alpha'alpha' or alphaalpha'), which are essential for cell viability, and a dimer of two non-catalytic beta subunits, whose precise function is still poorly understood. Although the beta subunits deeply affect many properties of CK2, both the isolated catalytic subunits and the holoenzyme are constitutively active, which is probably responsible for the oncogenic potential of CK2. Given the structure of the holoenzyme, the beta subunits could undergo reversible dissociation under physiological conditions and play a role as anchoring elements and/or as a docking platform for protein substrates and effectors. These unusual features are likely to be instrumental in the involvement of CK2 in a number of key biological functions, notably RNA synthesis, Wnt signaling, ubiquitination and cell survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244125     DOI: 10.1242/jcs.00074

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  181 in total

1.  Role of PI 3-kinase and PIP3 in submandibular gland branching morphogenesis.

Authors:  Melinda Larsen; Matthew P Hoffman; Takayoshi Sakai; Justin C Neibaur; Jonathan M Mitchell; Kenneth M Yamada
Journal:  Dev Biol       Date:  2003-03-01       Impact factor: 3.582

Review 2.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

3.  Cleavage and proteasome-mediated degradation of the basal transcription factor TFIIA.

Authors:  Torill Høiby; Dimitra J Mitsiou; Huiqing Zhou; Hediye Erdjument-Bromage; Paul Tempst; Hendrik G Stunnenberg
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

4.  Protein kinase CK2: a new view of an old molecular complex.

Authors:  Odile Filhol; Jean-Louis Martiel; Claude Cochet
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

5.  CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37.

Authors:  Yoshihiko Miyata; Eisuke Nishida
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

6.  Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.

Authors:  Béatrice Laudet; Caroline Barette; Vincent Dulery; Olivier Renaudet; Pascal Dumy; Alexandra Metz; Renaud Prudent; Alexandre Deshiere; Otto Dideberg; Odile Filhol; Claude Cochet
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

7.  CK2 is responsible for phosphorylation of human La protein serine-366 and can modulate rpL37 5'-terminal oligopyrimidine mRNA metabolism.

Authors:  Elena I Schwartz; Robert V Intine; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.

Authors:  Xiang Li; Bin Guan; Sam Maghami; Charles J Bieberich
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina.

Authors:  Andrei A Kramerov; Mehrnoosh Saghizadeh; Hao Pan; Andrea Kabosova; Mathias Montenarh; Khalil Ahmed; John S Penn; Candy K Chan; David R Hinton; Maria B Grant; Alexander V Ljubimov
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

10.  Identification of a novel protein interaction motif in the regulatory subunit of casein kinase 2.

Authors:  Jennifer Yinuo Cao; Kathy Shire; Cameron Landry; Gerald D Gish; Tony Pawson; Lori Frappier
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.